🩸 The Unlikely Hero: A Self-Immunizing Snake Enthusiast
Enter Timothy Friede, a truck mechanic-turned-herpetologist who:
Survived 200+ snakebites (including cobras, mambas)
Injected himself 500+ times with venom over 18 years
Developed unprecedented immunity
“I’ve been waiting for this call for a long time.”
— Friede, when scientists finally reached out
🧪 The Science: From Blood to Broad-Spectrum Antidote
1️⃣ Antibody Library: Isolated 2 billion antibodies from Friede’s blood
2️⃣ Toxin Neutralization: Identified antibodies blocking conserved neurotoxin sites
3️⃣ Cocktail Trial: Combined antibodies + drug (varespladib) → 100% survival in mice against 13/19 deadly venoms
Why It Matters: This approach could lead to the first universal antivenom—effective across species.
🌍 Next Steps & Challenges
✅ Clinical Trials: Testing in larger animals (real bites ≠ controlled lab doses)
⚠ Ethical Caution: “Self-immunization is life-threatening,” warns venom expert Kartik Sunagar
💡 Future Impact: Cheaper, safer, globally accessible treatment
#snake #venom #vaccine #antidote #TimothyFriede #antivenom
Reference
- León G, et al. Pathogenic mechanisms underlying adverse reactions induced by intravenous administration of snake antivenoms. Toxicon. 2013;76:63-76.
- Glanville J, et al. Snake venom protection by a cocktail of varespladib and broadly neutralizing human antibodies. Cell. 2025
- Lewin MR, et al. Varespladib in the treatment of snakebite envenoming: Development history and preclinical evidence supporting advancement to clinical trials in patients bitten by venomous snakes. Toxins. 2022;14(11):783.
Comments
Post a Comment